PMS Symptoms and Impact Research Abstract – DR.VEGAN

PMS Symptoms and Impact Research Abstract

The Symptom Burden, Behavioural Impact, and Coping Strategies of Premenstrual Syndrome: Findings from a Cross-Sectional Survey of 265 Women

March 2023

Key Findings

  1. 95.4% of respondents reported at least one regular PMS symptom; the mean number of symptoms per respondent was 8.3 (median 9), with 61.6% reporting seven or more and 42.6% reporting ten or more.
  2. Mood swings were the most prevalent symptom (70.5%) and most frequently rated as most disruptive (39.6%); 81.5% of respondents described themselves as snappy/irritable during PMS and 80.7% as tired/sluggish.
  3. 66.4% ate less healthily during PMS and 67.3% found it more difficult to exercise – creating a negative feedback loop with their broader health.
  4. 67.6% reported that PMS impacted their relationships; 40.7% had taken time off work or education due to PMS, yet 76.9% felt their employer or school did not understand or support them.
  5. No widely used coping strategy achieved a mean effectiveness score above 7/10; giving in to cravings, the fourth most widely used strategy, scored just 4.68, with only 18.8% rating it 7 or above.
  6. Only 21.3% of respondents felt they had received adequate period education at school; 30.6% received none at all.

Background

Premenstrual Syndrome (PMS) is a cyclical condition characterised by physical, psychological, and behavioural symptoms in the luteal phase of the menstrual cycle. Despite affecting a large proportion of reproductive-age women, PMS remains underdiagnosed, poorly supported in educational and occupational settings, and inadequately researched. This study aimed to characterise the breadth and severity of PMS symptoms and their impact on daily functioning, relationships, and work and to describe the coping strategies women currently employ, including their rated effectiveness. The survey was conducted by DR.VEGAN®, March 2023.

Methods

A cross-sectional online survey was administered to 265 women. Individual-level response data were available for all analyses. The survey captured the dietary profile; clinical diagnoses of PMDD and PCOS; hormonal medication use; subjective emotional experience of PMS; regularly experienced physical and psychological symptoms; the most disruptive symptoms; behavioural changes during the menstrual cycle; coping strategy use and rated effectiveness (1–10 scale); period education experience; and the impact of PMS on relationships, work, and educational attendance. Respondents who did not answer a given question were excluded from the denominator for that question.

Results

Sample characteristics

Of 265 respondents, 61.9% followed an omnivorous diet, 15.5% were vegan, 9.8% vegetarian, and 6.4% pescatarian. The majority (89.8%) had no formal diagnosis of PMDD or PCOS; 3.8% had been diagnosed with PMDD and 6.4% with PCOS. Most respondents (67.9%) were not taking any hormonal medication; 15.1% were taking HRT, and 10.9% were on hormonal contraception.

Emotional experience of PMS

When asked to describe how PMS makes them feel, respondents overwhelmingly selected negative descriptors. Positive descriptors were almost entirely absent, with only 7.1% selecting ‘normal’. See Figure 1.

Figure 1. Emotional experience of PMS: descriptors selected by respondents (n=238)Rows ordered by frequency.
Emotional descriptor % selecting (n=238)
Snappy / irritable 81.5%
Tired / sluggish 80.7%
Anxious 63.9%
Sad 52.1%
Depressed 49.6%
Self-conscious 42.9%
Normal 7.1%
Confident 0.8%
Productive 0.8%
Happy 0.4%
Proud 0.0%
Multiple responses permitted. % = proportion of 238 respondents selecting each descriptor. Top three negative descriptors highlighted. Positive descriptors (confident, productive, happy, proud) were near-absent.

Symptom prevalence and burden

Of 237 respondents, 95.4% reported at least one regular PMS symptom. The mean number of symptoms per respondent was 8.3 (median 9), with 61.6% reporting seven or more and 42.6% reporting ten or more. See Figure 2 for the full symptom prevalence profile.

Figure 2. PMS symptom prevalence across all respondents (n=237)Rows ordered by prevalence.
Symptom n (of 237) Prevalence
Mood swings 167 70.5%
Bloating and wind 162 68.4%
Back pain 142 59.9%
Less energy 133 56.1%
Tummy pain 132 55.7%
Poor concentration / brain fog 122 51.5%
Breast tenderness 118 49.8%
Depressed / mild depression 116 48.9%
Changes in appetite or cravings 113 47.7%
Headaches or migraines 109 46.0%
Trouble sleeping / insomnia 100 42.2%
Weight gain (fluid retention) 94 39.7%
Spotty skin / breakouts 91 38.4%
More frequent bowel movements 80 33.8%
Joint or muscle pain 78 32.9%
Changes in sex drive 76 32.1%
Mean symptoms per respondent: 8.3 (median 9); 61.6% report 7+ symptoms. % = proportion of 237 respondents reporting each symptom regularly. Multiple responses permitted. Top two symptoms highlighted. The summary row shows mean and median symptom burden. Rows ordered by prevalence.

Most disruptive symptoms

Of 217 respondents who identified their most disruptive symptoms (up to three), mood swings were by far the most frequently cited (39.6%), followed by depressed or mild depression (24.4%), trouble sleeping or insomnia (23.5%), and bloating (22.6%). Psychological and neurological symptoms were perceived as the greatest disruptors of daily life. See Figure 3.

Figure 3. Most disruptive PMS symptoms cited by respondents (n=217)Multiple responses permitted (up to three). Rows ordered by frequency.
Most disruptive symptom % citing as most disruptive (n=217)
Mood swings 39.6%
Depressed / mild depression 24.4%
Trouble sleeping / insomnia 23.5%
Bloating and wind 22.6%
Headaches or migraines 19.8%
Poor concentration / brain fog 18.0%
Tummy pain 16.1%
Less energy 16.1%
Back pain 8.3%
Joint or muscle pain 7.4%
% = proportion of 217 respondents citing each symptom as one of their most disruptive (up to three permitted). Mood swings are highlighted as most frequently cited. Rows ordered by frequency.

Behavioural impact

PMS was associated with significant negative changes in diet and exercise behaviour. See Figure 4 for the directional impact on these two key health behaviours.

Figure 4. Behavioural impact of PMS on diet quality and exercise capacity (n=223 per question)
Behaviour affected Worsens during PMS Improves during PMS
Diet quality (n=223) 66.4% 4.9%
Ability to exercise (n=223) 67.3% 1.8%
% = proportion of 223 respondents selecting each direction of change. ‘No change’ and ‘unsure’ not shown; total may not sum to 100%. Only 4.9% ate more healthily and 1.8% exercised more easily during PMS.

Coping strategies and effectiveness

Of 221 respondents, the most widely adopted coping strategies were ibuprofen (46.2%), vitamins or supplements (44.3%), paracetamol (42.5%), and giving in to cravings (39.8%). Effectiveness was rated on a 1–10 scale. Notably, no widely used strategy achieved a mean score above 7/10, highlighting the substantial unmet need for effective PMS management. See Figure 5 for uptake and effectiveness data across all strategies.

Figure 5. PMS coping strategies: uptake and effectiveness ratings (n=221 for uptake; n varies per strategy)Rows ordered by uptake.
Coping strategy % using (n=221) n using Mean score (/10) % scoring 7+
Ibuprofen 46.2% 102 6.33 50.5%
Vitamins or supplements 44.3% 98 6.24 46.9%
Paracetamol 42.5% 94 5.82 35.6%
Giving in to cravings 39.8% 88 4.68 18.8%
Hot water bottle / strap 38.5% 85 6.41 50.5%
Exercise 21.3% 47 6.91 58.7%
Drinking more water / hot drinks 19.9% 44 5.94 37.5%
Mindfulness / stress reduction 19.9% 44 6.08 43.2%
Sleeping longer 18.1% 40 5.72 32.5%
Antidepressants 10.9% 24 6.29 54.2%
% using = proportion of 221 respondents using each strategy. The mean score and % scoring 7+ calculated from users of each strategy. 1–10 effectiveness scale.

Vitamins/supplements highlighted

Giving in to cravings is highlighted as the weakest performer. No strategy achieved a mean score above 7.
Social and occupational impact. PMS had substantial consequences beyond the individual. See Figure 6 for the full social, occupational, and educational impact profile.

Figure 6. Social, occupational, and educational impact of PMS
Impact area % affected
PMS impacts relationships (n=216) 67.6%
Has taken time off work / education due to PMS (n=216) 40.7%
Employer / school does not understand or support them (n=216) 76.9%
Received no PMS / period education at school 30.6%
Received some but inadequate period education 48.1%
Received well-rounded period education 21.3%
% reporting relationships impacted, time off work, and lack of support from n=216 respondents. Period education data from n=265. Top three social/occupational impacts highlighted.

Education and awareness

Only 21.3% reported being well-educated on PMS / period health at school, while 48.1% received some but inadequate education and 30.6% received none at all. Respondents repeatedly called for better education for both girls and boys, greater GP awareness, and broader societal normalisation of menstrual health.

Conclusions

This survey of 265 women demonstrates that PMS imposes a high and multi-dimensional burden, with a mean of 8.3 symptoms per respondent and over 60% experiencing seven or more. Psychological symptoms, particularly mood swings, anxiety, low mood, and brain fog, are experienced as the most disruptive. The condition significantly affects eating habits, exercise capacity, relationships, and occupational attendance, yet institutional support is largely absent (76.9% feel unsupported). Current coping strategies provide only partial relief, and none approaches complete symptom resolution. These findings point to an urgent need for improved clinical recognition, workplace accommodation, school education, and evidence-based non-pharmacological interventions for PMS.

Keywords: PMS, premenstrual syndrome, menstrual health, mood swings, bloating, brain fog, coping strategies, occupational impact, women’s health, period education

Survey date: March 2023  |  Sample size: N = 265  |  Data: Individual-level responses  


Media enquiries: Please contact [email protected]

 

Basket

Your shopping basket is empty. Need some help?
Our Virtual Nutritionist is here to assist you.

Try now

Add to your stack

Gut Works®

Gut Works®

(410)
£32.99

Vegan Omega 3

Vegan Omega 3

(72)
£21.99

Magnesium Glycinate

Subtotal

£0.00

Shipping and taxes calculated at checkout.